Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Clarus files for $86M IPO as cash run dries

This article was originally published in Scrip

Executive Summary

Driving on fumes, Clarus Therapeutics, the US biopharmaceutical company, is turning to the public markets in attempt to bolster its finances. The company has filed plans to raise up to $86.25 million in an IPO after its cash and equivalents fell to just $483,000 at the end of September.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register